Vaccination has become an important means to prevent and control the new crown epidemic
Recently, a research team such as Johns Hopkins University in the United States published a study in the journal Transplantation: Compared with the general population, organ transplant recipients have low resistance to new coronavirus infection after vaccination
In general, vaccines fight the virus by triggering specific immune memory
However, in organ transplant recipients, many of these immune responses have been weakened
In this study, the researchers estimated the breakthrough infection rate of organ transplant recipients after being vaccinated with the mRNA new crown vaccine, and compared it with the infection rate of the general population
Research data shows that compared with the general population, the risk of breakthrough infection in the organ transplant recipients in the study is 82 times higher, and the risk of breakthrough infection accompanied by hospitalization and death is 485 times higher
The data of the study was collected in an aggregated manner, and other researchers were contacted through the PudMed and Scopus databases to identify 17 transplant centers that can provide relevant research information for organ transplant recipients
In addition, many organ transplant centers that provide data to researchers also stated that the number of new coronavirus infections among organ transplant recipients treated at their centers is not a complete statistics
In view of the high rate of breakthrough infections in this population, the researchers urged that organ transplant recipients should continue to implement recommended safety protection measures, such as wearing masks and maintaining social distancing.
It is worth noting that although studies have shown that organ transplant recipients have a much higher risk of breakthrough infection than ordinary people, vaccination does seem to provide protection
How to provide vaccine protection for organ transplant recipients more effectively? Recently, there have also been some studies on the new crown vaccination strategy for organ transplant recipients, supporting the potential efficacy of the third dose of vaccine and booster vaccine
Focus on the new crown pneumonia epidemic
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
